CureBay raises ₹100 Cr to expand rural clinics, AI screening

The capital will fuel expansion of its rural clinic network and further development of its AI-driven screening tools, as the company works toward operational profitability.

The round underscores growing investor interest in models addressing gaps in India’s rural healthcare system. CureBay bridges these gaps by connecting patients in underserved areas to doctors, diagnostics, and pharmacies through a hybrid approach—combining physical clinics, community health workers, and a digital platform. The startup is now eyeing new markets beyond its current footprint, with plans to significantly increase its clinic presence in the coming years.

AI remains a core focus of the expansion. The company already uses machine learning for various screening applications and is investing in infrastructure to broaden these capabilities. Leadership has indicated plans to expand both the range and depth of its AI products, though the timeline for these developments remains fluid. Alongside its tech investments, CureBay has introduced a subscription program designed to promote preventive care, bundling consultations, diagnostics, and hospitalization support.

The funding arrives as the company reports strong revenue growth. While exact figures are unaudited, CureBay claims to have achieved operational EBITDA breakeven in its last fiscal year, with a monthly run rate that has since grown. Leadership has suggested profitability at the overall company level will depend on reaching a more stable operating scale.

This dynamic—balancing growth with profitability—is common in healthtech, particularly for models targeting rural populations. CureBay’s approach, which integrates physical and digital care, reflects broader efforts to make healthcare more accessible while maintaining sustainable unit economics. The startup’s scale, including a reported patient base in the millions and a network spanning thousands of pincodes, could help justify its AI investments over time.

The round also highlights the increasing role of debt in healthtech funding. While equity investors have provided the bulk of CureBay’s prior capital, the debt component suggests lenders are willing to back models with clear revenue streams. This trend could encourage other startups in the space to explore similar financing structures.

For now, CureBay’s focus is on execution. The coming year will test whether its AI tools can improve outcomes enough to drive higher customer engagement—a key factor in its revenue growth. If successful, the model could serve as a blueprint for other startups aiming to serve India’s rural population without sacrificing financial sustainability. Investors, meanwhile, will watch whether the company can maintain its operational profitability while scaling, or if expansion costs will delay broader profitability.

Sources: inc42.com